medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2000, Number 1

<< Back Next >>

Alerg Asma Inmunol Pediatr 2000; 9 (1)

Chronic fatigue syndrome in children and adolescents

Correa BY, Ortega MJA Rosiles SG, Jiménez CI, Almendares FC, Berrón PR, Huerta LJG

Language: Spanish
References: 53
Page: 21-31
PDF size: 615.57 Kb.


ABSTRACT

Chronic Fatigue Syndrome (CSF) is a complex illness characterized by severe, incapacitating fatigue as well as numerous physical complains neurological impairments. The first report of the disease was in the 18th Century describing it as an illness of unknown etiology. The chronic fatigue is a common complain with an estimated prevalence of 24%. In 1988 the Chronic Fatigue Syndrome was defined by the experts due to an increase in the recognition of the disease. In 1988 The Center for disease Control and prevention (CDC) first established the diagnostic criteria in the United States, with a modification published in 1994. As well as other non well defined diseases, the diagnosis of the CFS in frequently done by exclusion of other conditions. Many cases have been reported around the word more common in women between 20-50 years of age. Several studies have described the epidemiology, symptoms and outcome of the chronic fatigue syndrome in children and adolescents. These studies have demonstrates many similarities among children and adolescents, and adults with, chonic fatigue, but several important differences as well; children and adolescents generally present earlier for evaluation, more often have “pediatric” symptoms (such as abdominal pain) as prominent complains, and generally have an outcome that is much better than that reported in adults. Many different etiologies have been proposed for CFS. However, it is also possible that there are different etiologies or causative factors that results in the symptoms complex known as CFS. The treatment is mostly supportive.


REFERENCES

  1. Jordan MK, Landis DA, Meagan CD, Osterman S, Thurm AE, Jason AL. Fatigue syndrome in children and adolescents: A review. Journal of adolescents Healt 1998; 22: 4-18.

  2. Chronic fatigue syndrome. National Institute of Allergy and Infectious Diseases. National Institutes of Health US. Public Health Service 1992.

  3. Wright JB. Chronic fatigue syndrome. Arch Dis Child 1998; 79: 368-374.

  4. Thomas PK. El síndrome de fatiga crónica: ¿Qué es lo que sabemos? BMJ 1993; 1: 299-300.

  5. Franklin A. How I manage chronic fatigue syndrome. Arch Dis Child 1998; 79: 375-378.

  6. Borish Larry, Schaling Kareni, Di Clementi D, Joanne Streib, Negri J, Jones J. Chronic fatigue syndrome: Iden tific stion of distict sub group on the basis of allergy and psychologic variables. J Allergy Clin Immnul 1998; 102: 122-230.

  7. Mawle A, Niesenbaum R, Dobbins J, Howard G, Steward J, Reyes M, Steele L, Shmid S, Reeves W. Immune responses associated with chronic fatigue syndrome: a case-control study. JID 1997; 175: 136-141.

  8. Krilov L, Fisher M, Fridman S, Reitman D, Mandel F. Course and outcome of chronic fatigue in children and adolescents. Pediatrics 1998; 102: 360-366.

  9. Andersson M, Bagby JR, Dyrehag L, Gotffries C. Effects of staphylococcus toxoid vaccine on pain and fatigue in patients with fibromyalgia/chronic fatigue syndrome. Eur J Pain 1998; 2: 133-142.

  10. Lee S, Yu H, Wing Y, Chan C, Lee AM, Lee DT, Chen CN, Lin K, Weiss MG. Psychiatric morbidity and illness experience of primary care patients with chronic fatigue in Hong Kong. Am J Psychiatry 2000; 1; 157: 380-384

  11. Berg D, Berg LH, Couvaras J, Harrison H. Chronic fatigue syndrome and/or fibromyalgia as a variation of antiphospholipid antibody syndrome: an explanatory model and approach to laboratory diagnosis. Blood Coagui Fibrinolysis 1999; 10: 435.

  12. Llord A, Maryland F, Hickie J, Brockman A, Hickie C, Wilson A, Dwyer J, Wakefield D. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double blind placebo-controlled trial. The American Journal of Medicine 1993; 94: 197-202.

  13. Besedovsky HE. Immune-neuroendocrine interactions. J Immunol 1985; 135: 750-753.

  14. Shavit Y, Terman G. Stress, opioid peptides, the immune system and cancer. J Immunol 1985; 135: 834-837.

  15. Masuda A, Nozoe SI, Matsuyama T, Tanaka H. Psychobehavioral and immunological characteristics of adult people with chronic fatigue and patients with chronic fatigue syndrome. Psy Chosom Med 1994; 56: 512-8.

  16. Ogawa M, Nishiura T, Yoshimura M, Horikawa Y, Yoshida H, Okajima Y, Matsumura I, Ishikawa J, Nakao H, Tomiyama Y, Kanayama Y, Kahakura Y. Matsuzawa decreased nitric oxide-mediated natural killer cell activation in chronic fatigue syndrome. Eur J Clin Invest 1998; 28: 937-43.

  17. Uchida A. Chronic fatigue immune dysfunction syndrome. Nippon Rin Sho 1992; 50: 2625-1629.

  18. Tirelli U, Marotta G, Improta S, Pinto A. Immunological abnormalities in patients with chronic fatigue syndrome. Scand J Immunol 1998; 40: 601-608.

  19. Morrison LJ, Behan WH, Behan PO. Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Clin Exp Immunol 1991; 83: 441-6.

  20. Barker E, Fujimura SF, Fadem MB, Landay AL, Levy JA. Immunologic abnormalities associated, with chronic fatigue syndrome. Clin Infect Dis 1994; 18 Suppl(20): S136-41.

  21. Ojo-Amaize EA, Conley EJ, Peter JB. Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome. Clin Infect Dis 1994; 18 Suppl(1): S157-9.

  22. Uchida A. Therapy of chronic fatigue syndrome. Nippon Rinsho 1992; 50: 2679-83

  23. Gewitz MH, Weldon A, Arlievsky N, Li K, Munoz J, Stewad JM. Orthostatic intolerance in adolescent chronic fatigue syndrome. Pediatrics 1999; 103: 116-21.

  24. Levine PH, Whiteside TL, Friberg D, Bryant J, Colclough G, Herberman RB. Dysfunction of natural killer activity in a family with chronic fatigue syndrome. Clin Immunol Immunopathol 1998; 88: 96-104.

  25. Itoh Y, Hamada H, Imai T, Seki T, Igarashi T, Yuge K, Fukunaga Y, Yamamoto M. Antinuclear antibodies in children with chronic nonspecific complaints. Autoimmunity 1997; 25(4): 243-50.

  26. Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. QJM 1997; 90: 223-33.

  27. Rowe KS. Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic, fatigue syndrome in adolescents. J Psychiatr Res 1997; 31: 133-47.

  28. Kavelaars A, Kuis W, Knook L, Sinnema G, Heijnen CJ. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 2000; 85: 692-6.

  29. Kakumanu S, Yeager M, Craig T. Chronic fatigue syndrome. J Am Osteopath Assoc 1999; 99 (10 Su Pt 1): S1-5.

  30. Shlaes JL, Jason LA, Ferrari J. The development of the Chronic Fatigue Syndrome Attitudes Test. A psychometric analysis. Eval Health Prof 1999; 22: 442-65.

  31. Nous G, Molson J. Competition for glutathione precursors between the immune system and the skeletal muscle: pathogenesis of chronic fatigue syndrome. Med Hypotheses 1999; 53: 347-9.

  32. Korszun A, Sackett-Lundeen L, Papadopoulos E, Brucksch C, Masterson L, Engelberg NC, Haus E, Demitrack MA, Crofford L. Melatonin levels in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 1999; 26: 2675-80.

  33. Garralda E, Rangel L, Levin M, Roberts HU, Koumunne O. Psychiatric adjustment in adolescents with a history of chronic fatigue syndrome. J Am Acad Child Adolesc Psychiatry 1999; 38: 1515-21.

  34. Pheley AM, Melby D, Schenck C, Mandel J, Peterson PK. Can we predict recovery in chronic fatigue syndrome? Minn Med 1999; 82: 52-6.

  35. Evengard B, Schactedle RS, Komaroff AL. Chronic fatigue syndrome: new insights and old ignorance. J Intern Med 1999; 246: 455-69.

  36. Lange G, DeLuca J, Maldjian JA, Lee H, Tiersky LA, Natelson BH, Brain MRI. Abnormalities exist in a subset of patients with chronic fatigue syndrome. J Neurol Sci 1999; 1 171: 3-7.

  37. Moss RB, Mercandetti A, Vojdani A. TNF-alpha and chronic fatigue syndrome. J Clin Immunol 1999; 19: 314-6.

  38. Gordon R, Michalewski HJ, Nguyen T, Gupta S, Starr A. Codical motor potential alterations in chronic fatigue syndrome. Int J Mol Med 1999; 4: 493-9.

  39. Hill NF, Tiersky LA, Scavalla VR, Lavietes M, Natelson BH. Natural history of severe chronic fatigue syndrome. Arch Phys Med Rehabil 1999; 80: 1090-4.

  40. van der Linden G, Chalder T, Hickie I, Koschera A, Sham P. Wessely Fatigue and psychiatric disorder. Different or the same? Phol Med 1999; 29: 863-8.

  41. Scott LV, Salahuddin F, Cooney J, Svec F, Dinan TG. Differences in adrenal steriod profile in chronic fatigue syndrome, in depression and in healths. J Affect Disord 1999; 54: 129-37.

  42. Natelson BH, Denny T, Zhou XD, LaManca JJ, Ottenweller JE, Tiersky L, Deluca J, Gause WC. Is depression associate with immune activation?

  43. Glover DM. Chronic Fatigue Syndrome. Adolesc Med 1995; 6: 101-114.

  44. Buckley L, MacHale SM, Cavanagh JT, Charpe M, Deary IJ, Lawrie SM. Personality dimensions in chronic fatigue syndrome and depression. Aust NZ J Psychiatri 1999; 33(2): 278-80.

  45. Kronenberg WG, Edwards JF, Marshall GS, Schikler KN, Causey DL. Psychological symptoms in chronic fatigue and juvenile rheumatoid arthritis.

  46. Farmer A, Scoufield J, Martin N, Cardno A, McGuffin P. Is disabling fatigue in childhood influenced by genes? Psychol Med 1999; 29: 279-82.

  47. Vojdany A, Choppa PC, Lapp CW. Downregulation of RNase L inhibitor correlates with upregulation of interferon-induced proteins (2-5A synthetase and RNase L) in patients with chronic fatigue immune dysfunction syndrome. J Clin Lab Immunol 1998; 50: 1-16.

  48. Forsyth LM, Preuss HG, MacDowell AL, Chiazze L Jr, Birkmayer GD, Bellanti JA. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Annals Allergy Clinn Immunol 1999.

  49. Cleare AJ, Heap E, Malhi GS, Wessely S, O’Keane V, Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomized crossover trial. Lancet 1999; 6: 353(9151): 455-8.

  50. Baraniuk JN, Clauw DJ, Gaumond E. Rhinitis symptoms in chronic fatigue syndrome. Ann Allergy Asthma Immunol 1998; 81: 359-65.

  51. Borish L, Schmaling K, DiClementi JD, Streib J, Negri J, Jones JF. Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychologic variables. J Allergy Clin Immunol 1998; 102: 222-30.

  52. Scott LV, Medbac S, Dinan TG. The low dose ACTH test in chronic fatigue syndrome and in health. Clin Endocrinol (Oxf) 1998; 48: 733-7.

  53. Cannon JG, Angel JB, Abad LW, O’Grady J, Lundgren N, Fagioli L, Komaroff AL. Hormonal influencies on stress-induced neutrophil mobilization in health and chronic fatigue syndrome. J Clin Immunol 1998; 18: 291-8.




2020     |     www.medigraphic.com